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E-mail address: cllin@ntu.edu.sg (V.C.L. Lin).Tripartite motif-containing 22 (TRIM22) is an important antiviral protein that forms distinct nuclear
bodies (NB) in many cell types. This study aims to identify functional domains/residues for TRIM22’s
nuclear localization and NB formation. Deletion of the really-interesting-new-gene (RING) domain,
which is essential for its antiviral property, abolished TRIM22 NB formation. However, mutation of
two critical residues Cys15 and Cys18 to alanine in the RING domain, did not affect NB formation
notably. Although the deletion of the putative bipartite nuclear localization signal (NLS) abolished
TRIM22 localization and NB formation, the B30.2/SplA and ryanodine receptor (SPRY) domain, and
residues 491–494 speciﬁcally are also essential for nuclear localization and NB formation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction TRIM22 was ﬁrst identiﬁed as an interferon-induced proteinTripartite motif-containing 22 (TRIM22) is a member of the
TRIM family of proteins that have a conserved domain structure,
consisting of a really-interesting-new-gene (RING) domain, fol-
lowed by one or two B-box domains, a coiled-coil (CC) domain
and a B30.2/SplA and ryanodine receptor (SPRY) domain at its C-
terminus [1]. The RING domain in several tripartite motif-contain-
ing (TRIM) proteins has E3 ligase activity, a function that appears
to be critical for the roles of these proteins in growth, development
and antiviral activity [2–6]. In several TRIM proteins, B-box do-
mains mediate protein–protein interactions [7,8]. The CC domain
is largely responsible for homomultimerization [1,8,9]. On the
other hand, the function of the B30.2/SPRY domain is not well de-
ﬁned. Amino acid variability in the hydrophilic regions and the
inherent ﬂexibility found in certain regions of the B30.2/SPRY do-
main suggest that these domains can modulate the conformation
of TRIM proteins and thereby determine their speciﬁcities and reg-
ulate their functions [10–12]. The different domains in TRIM pro-
teins can also work coordinately to modulate TRIM protein
localization and elicit speciﬁc functions as shown for TRIM5a
and the Xenopus TRIM protein Nuclear Factor 7 [1,13,14].chemical Societies. Published by E
o-2-phenylindole; FCS, fetal
n signal; PML, promyelocytic
plA and ryanodine receptor;
otif-containing 22and named stimulated transacting factor of 50 kDa. It has also been
shown to be p53-inducible and to inhibit clonogenic leukemic cell
growth and HIV-1 infection in several cell types when over-
expressed [15–17]. There is also evidence that TRIM22 interferes
with viral gene transcription and Gag protein localization [18,19].
While the ability of TRIM22 to inhibit HIV-1 replication was shown
to depend on RING-ﬁnger cysteine residues at positions 15 and 18
(Cys15, Cys18), the E3 ligase activity of TRIM22 and its ability to
self-ubiquitinate depended on Cys15 [2,19].
Nuclear bodies (NB) are nuclear subdomains that are implicated
in a number of nuclear functions including ribogenesis, regulation
of transcription and the cell cycle [20,21]. Cajal bodies are better
characterized NB marked by the presence of p80-coilin [21]. Sev-
eral TRIM family proteins including PML/TRIM19, TIF1/TRIM24
and RFP/TRIM27 also form NB. The best characterized one is the
promyelocytic leukemia (PML) body which was ﬁrst identiﬁed as
a fusion of PML’s N-terminal RBCC domain with the retinoic acid
receptor alpha in acute promyelocytic leukemia [22,23]. PML has
been found to be involved in DNA repair, apoptosis, and telomere
maintenance and antiviral function [20,24–26].
We have recently reported that endogenous TRIM22 forms dis-
tinct NB that undergo dynamic changes during cell cycle progres-
sion, in which TRIM22 NB started to form in the early G0/G1
phase but became speckle-like in the S-phase and completely dis-
persed in mitosis [27]. The TRIM22 NB did not co-localize with
PML NB but up 35% of TRIM22 NB overlapped or were found adja-
cent to Cajal bodies. These observations suggest the TRIM22 NB islsevier B.V. All rights reserved.
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was to identify the domain/residues that are important in TRIM22
nuclear localization and NB formation. The results revealed that
the RING domain, but not two of the functional residues Cys15
and Cys18, is required for TRIM22 NB formation.While the putative
bipartite nuclear localization signal (NLS) [18] does contribute to
nuclear localization, the B30.2/SPRY domain and residues 491–
494 speciﬁcally, are critical for nuclear localization and the NB for-
mation. These ﬁndings not only provide the basis for further eluci-
dating the structure–function relationship of TRIM22 but also offer
insight into the contribution of different domains to NB formation
in general.
2. Materials and methods
2.1. Cell lines and culture
MCF7 cells were from American Type Culture Collection. HeLa
cells were from Dr. Koh Cheng Gee (Nanyang Technological Univer-
sity, Singapore). All cells were routinely maintained in phenol-red
containing DMEM supplemented with 7.5% fetal calf serum (FCS),
2 mM glutamine and 40 lg/ml gentamycin.
2.2. Cloning of TRIM22 and mutants
The TRIM22 coding sequence was ampliﬁed from RZPD clone
TRIM22-pCMV-SPORT6 (IMAGE id: 5583800) using Pfu polymerase
and veriﬁed by sequencing. The TRIM22 amplicon and mutants
were cloned into the pXJ-FLAG vector [28] using restriction en-
zymes from New England Biolabs. TRIM22 Cys15 and Cys18 mu-
tants were generated from FLAG-TRIM22 by site-directed
mutagenesis (Stratagene). Point mutations at the C-terminal end
were introduced into FLAG-TRIM22 using mutant primers. Inserts
and ﬂanking regions were sequenced to ensure tags were in frame.
2.3. Immunoﬂuorescence
Cells were transfected with constructs using Fugene 6 (Roche
Diagnostics) for 24–48 h before they were ﬁxed with 3.7% formal-
dehyde, permeabilized with 0.2% Triton-X 100, and blocked with
2% FCS/PBS for 1–2 h. Cells were incubated with anti-FLAG anti-
body (M2) (Sigma–Aldrich) in 2% FCS/PBS for 2 h at 37 C or over-Fig. 1. TRIM22 deletion mutants were cloned into the pXJ-FLAG vector to investigate
formation.night at 4 C, and then incubated with Alexa Fluor 633 nm anti-
mouse IgG (Invitrogen) and 40,6-diamidino-2-phenylindole (DAPI)
(Sigma–Aldrich) (0.1 lg/ml) in 2% FCS/PBS for 2 h at 37 C before
mounting on glass slides using anti-fade ﬂuorescence mounting
media (Invitrogen). Images were acquired as black and white TIFF
ﬁles with an Olympus Manual Reﬂected Fluorescence System at-
tached to an Olympus DP30BW Digital Camera (Olympus Singa-
pore Pte. Ltd., Singapore) using a 60X UPlanSApo oil objective.
Color was added using DP Manager (Olympus).
2.4. Cell fractionation and Western blotting analysis
MCF7 cells transfected with various expression plasmids for
48 h were pelleted, re-suspended in buffer S1 (10 mM Hepes pH
7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5% NP-40, 10 mM DTT, 5 lg/ml
pepstatin A, 5 lg/ml leupeptin, 2 lg/ml aprotinin), incubated on
ice for 10 min, before passing through a 21G syringe 10 times.
Cytoplasmic fractions were obtained as the supernatant after cen-
trifugation at 1000g for 10 min. The resultant pellet was re-sus-
pended in buffer S2 (10 mM Hepes pH 7.9, 1.5 mM MgCl2, 0.4 M
KCl, 0.5% NP-40, 10 mM DTT, 5 lg/ml pepstatin A, 5 lg/ml leupep-
tin, 2 lg/ml aprotinin), passed through a 29G syringe 10 times,
then centrifuged (20 000g, 15 min) to obtain the nuclear fraction
in the supernatant. Protein was quantitated and Western blotting
analysis was carried out as previously described [29].
3. Results and discussion
To identify regions/residues that are critical for the nuclear
localization and NB formation of TRIM22, a series of TRIM22 mu-
tant constructs were cloned into the pXJ-FLAG vector (Fig. 1).
Expression constructs expressed proteins of expected sizes (Sup-
plementary Fig. 1). To exclude artifacts resulting from excessive
over-expression, images of cells with relatively low levels of ﬂuo-
rescence are presented.
3.1. The RING domain is required for the NB formation but is not
necessary for nuclear localization of TRIM22
The RING domain is a zinc-binding motif that typically func-
tions as an E3 ubiquitin ligase to regulate protein stability via the
ubiquitination pathway [30]. TRIM22 was found to undergo self-the contribution of the different domains to TRIM22 nuclear localization and NB
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The antiviral property of TRIM22 also depends on its RING domain
and residues Cys15 and Cys18 are critical for its E3 ligase activity
[2,19]. We have shown previously using antibodies speciﬁc for
TRIM22 that TRIM22 forms distinct NB in several cell lines [27].
FLAG-tagged wild-type TRIM22 localized much like endogenous
TRIM22 [27] (Fig. 2A). Deletion of the RING domain abolished
TRIM22 NB formation (Fig. 2A). This is consistent with the report
that the RING domain is essential for the formation of PML bodies
[31]. However, mutating Cys15 and Cys18 to alanine residues
(TRIM22-C15A and TRIM22-C15A,C18A) did not abrogate the for-
mation of TRIM22 NB (Fig. 2A). On the other hand, mutations in
PML’s RING ﬁnger domain have been found to alter the subcellular
localization of PML from punctuate NB to a diffuse and speckled
nuclear staining [22,32] and also to inhibit PML’s growth suppres-
sive and apoptotic effects [33,34]. In the case of TRIM22, mutation
of Cys15 and Cys18 may not dramatically affect the structure ofFig. 2. Subcellular localization of TRIM22 and deletion mutants. (A) MCF7 cells expressing
and counterstained with DAPI (blue). Cells were imaged at a 60magniﬁcation. Bars, 20 l
the merged image. Insets show representative cells (arrows) enlarged 2. (B) Cytoplasm
indicated TRIM22 constructs for 48 h were subjected to cell fractionation to obtain cytop
were analyzed by Western blotting with anti-FLAG antibody. The cytoplasmic protein G
fraction).TRIM22 to the point that NB fail to form, even though these resi-
dues have been found to be important for the catalytic activity of
the RING domain [2,19]. We speculate that the mutation of
Cys15 and Cys18 to alanine did not change the spatial arrangement
of the RING domain required for TRIM22 NB formation.
The RING domain does not seem to be required for the nuclear
localization of TRIM22 as TRIM22-DRING remains nuclear (Fig. 2A
and B). Further deletion of the B-box2 domain (TRIM22-DRING/B2)
did reduce the nuclear localization of the mutant to some extent
but the majority of TRIM22-DRING/B2 was still localized in the nu-
cleus (Fig. 2B). The protein also appeared to be concentrated at the
nuclear periphery (Fig. 2A). This is despite the fact that the 43 kDa
TRIM22-DRING/B2 may have been able to diffuse through nuclear
pores out into the cytoplasm [35]. Unlike TRIM22-DRING/B2,
TRIM22-DRING/B2/CC was localized diffusely throughout the cell
by immunostaining. It also appeared that TRIM22-DRING/B2/CC
was localized more in the cytoplasm by Western blotting analysisthe different deletion mutants were immunostained with anti-FLAG antibody (red)
m. Images showing staining with the anti-FLAG antibody are presented to the left of
ic and nuclear levels of TRIM22 and deletion mutants. MCF7 cells transfected with
lasmic and nuclear fractions. Levels of exogenous proteins in the different fractions
APDH was probed as a cytoplasmic marker (C: cytoplasmic fraction and N: nuclear
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the arrow) that showmore cytoplasmic staining. We speculate that
the CC domain may either play a speciﬁc role in the nuclear local-
ization of TRIM22, or it mediates homomultimerization of TRIM22-
DRING/B2 in the nucleus such that the formation of larger
complexes prevented the ‘leaking’ of the protein out of the nucleus.
3.2. The putative bipartite NLS is necessary for the nuclear localization
of TRIM22
The bipartite NLS consists of two clusters of positively charged
amino acids separated by a linker region of 10–12 amino acids
[36]. A putative bipartite NLS in the TRIM22 protein from residues
257–275 (KRSESWTLKKPKSVSKKLK) has been identiﬁed [18] but
the function of this sequence as an NLS has not been demonstrated.
Deletion of this putative NLS greatly impaired nuclear localization
and there seemed to be similar amount of TRIM22-DNLS in the
cytoplasm and in the nucleus in the Western blotting analysis
(Fig. 2B). However, the 57 kDa TRIM22-DNLS is unlikely to be
freely diffusible so the signiﬁcant presence of this protein in the
cytoplasm is likely caused by the absence of the NLS. We suggest
therefore that the predicted NLS is necessary for the efﬁcient im-
port of TRIM22 to the nucleus but may not necessarily be sufﬁcientFig. 3. Localization of TRIM22 mutants lacking 4, 5, 9 and 19 aa of the B30.2/SPRY doma
anti-FLAG antibody (red) and counterstained with DAPI (blue). Cells were imaged at a 60
are presented to the left of the merged image. Insets show representative cells (arrows
MCF7 cells transfected with the indicated constructs for 48 h were subjected to cell fracti
the different fractions were analyzed by Western blotting with anti-FLAG antibody. The
fraction and N: nuclear fraction).(Fig. 2). As will be seen later, the B30.2/SPRY domain also contains
important signal(s) for nuclear location of TRIM22. The sequence
257KRSESWTLKKPKSVSKKLK275 is likely to be important for protein
folding and protein–protein interactions since its deletion com-
pletely abolished the formation of TRIM22 NB.3.3. The B30.2/SPRY domain cooperates with the other regions for
nuclear localization and TRIM22 NB formation
The TRIM22 protein contains a 145 aa B30.2/SPRY domain at its
C-terminus. The domain has been suggested to play a critical role
in the conformations and functions of other TRIM proteins [10–
12]. We observed that TRIM22-DB30.2/SPRY failed to go into the
nucleus and formed cytoplasmic aggregates (Fig. 3A). This was
supported by cell fractionation results showing predominant cyto-
plasmic localization of TRIM22-DB30.2/SPRY (Fig. 3B). This sug-
gests that B30.2/SPRY domain is important for nuclear
localization of TRIM22. However the C-terminus deletion mutant
containing only the B30.2/SPRY domain (TRIM22-DRING/B2/CC/
182) also localized as cytoplasmic protein. Thus, the B30.2/SPRY
domain may collaborate with other sequences such as the putative
bipartite NLS to import TRIM22 into the nucleus.in. MCF7 cells expressing the different deletion mutants were immunostained with
magniﬁcation. Bars, 20 lm. Images showing staining with the anti-FLAG antibody
) enlarged 2. (B) Cytoplasmic and nuclear levels of B30.2/SPRY deletion mutants.
onation to obtain cytoplasmic and nuclear fractions. Levels of exogenous proteins in
cytoplasmic protein GAPDH was probed as a cytoplasmic marker (C: cytoplasmic
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the nuclear localization of TRIM22
Wewent on to identify a minimal stretch within the B30.2/SPRY
domain that was important for the nuclear localization of TRIM22.
Serial deletions of the protein from the C-terminal end revealed
that a mutant lacking the last ﬁve aa (TRIM22-B30.2/SPRYD5) con-
tinued to localize predominantly within the nucleus, whereas the
absence of the last nine aa (TRIM22-B30.2/SPRYD9) severely com-
promised nuclear localization (Fig. 3A), a ﬁnding which was sup-
ported by cell fractionation analysis (Fig. 3B). Therefore, residues
491–494 are important for the nuclear localization of TRIM22. As
mutation of these four residues individually did not impair nuclear
localization noticeably (data not shown), it is likely that the collec-
tive property of these residues, rather than that of the individual
residue, is important for the optimal folding and nuclear localiza-
tion of TRIM22.
3.5. Residues Val493 and Cys494 are required for the formation of
distinct TRIM22 bodies
Interestingly, unlike the TRIM22-B30.2/SPRYD4 mutant that
formed distinct NB much like wild-type TRIM22, the TRIM22-
B30.2/SPRYD5 mutant was unable to form NB (Fig. 3). Thus, the
critical residue for NB formation appears to be Cys494. To investi-
gate if a disulﬁde bond formed between this cysteine and another
cysteine in the protein was critical for NB formation, we mutatedFig. 4. A hydrophobic residue in position 493 and a residue in position 494 are import
V493L, V493A, and V493A,C494A). (B) Cellular localization of TRIM22 point mutants in M
with DAPI. Cells were imaged at a 60magniﬁcation. Bars, 20 lm. Images showing staini
show representative cells (arrows) enlarged 2. The arrowhead in the TRIM22-V493A,
protein. (C) Alignment of the last 20 residues of human TRIM22 with TRIM34, TRIM6 anCys494 to either an alanine residue (TRIM22-C494A) or a glutamic
acid residue (TRIM22-C494E). Both point mutants continued to
form distinct TRIM22 NB (Fig. 4A and B), implying Cys494 is critical
for NB formation because of the spatial positioning of the residue
rather than the formation of a disulﬁde bound with another
cysteine.
To identify additional determinants of NB formation, we com-
pared the TRIM22 sequence at its C-terminal end with those of
its paralogs TRIM6 and TRIM5a which exist as cytoplasmic speck-
les [1]. Alignment revealed that Val493 in TRIM22 is the only res-
idue within the last nine aa stretch that set it apart from TRIM6 and
TRIM5a, all of which have a leucine (L) residue in place of valine
(V) (Fig. 4C). Mutating Val493 to a leucine residue (TRIM22-
V493L) did not change the localization of the mutant as the NB
looked very similar to those formed by wild-type TRIM22
(Fig. 4B). In contrast, mutating Val493 to an alanine residue
(TRIM22-V493A) disrupted the formation of regular bodies, result-
ing in hollow rings in as many as 70% of the structures observed
(Fig. 4B). As both valine and leucine are hydrophobic amino acids,
they are typically inside of the protein. Conversely, the ambivalent
alanine may reside outside of the protein and this position may
disrupt partially the amino acid interactions necessary for NB
formation.
A few studies have reported the modiﬁcation of NB into hollow
ring-like structures as a result of interaction with other proteins or
mutants. For instance, CRAG (a GTPase) induced a ring-like struc-
ture of PML NB upon UV irradiation and the PML in this structureant for proper nuclear body formation. (A) TRIM22 point mutants (C494A, C494E,
CF7 cells. Cells were immunostained with anti-FLAG antibody and counterstained
ng with the anti-FLAG antibody are presented to the left of the merged image. Insets
C494A panel shows nuclear body formation in a cell expressing larger amount of
d TRIM5a.
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also observed when 285 aa was deleted from the C-terminus
of p80-coilin [38]. It remains to be tested if the TRIM22 NB and
the TRIM22-V493A mutant that formed the hollow ring structure
are functionally active.
When both Val493 and Cys494 were mutated to alanine resi-
dues (TRIM22-V493A,C494A mutant) the hollow ring structure
was no longer present (Fig. 4B). However, the propensity of the
TRIM22-V493A,C494A mutant to form regular bodies was greatly
reduced as judged by comparing the relative intensity of the NB
to the intensity of the nucleoplasmic ﬂuorescence. The double mu-
tant only formed bodies when expressed at high levels where a dif-
fused nucleoplasmic staining was also observed (see cell indicated
by the arrowhead). Collectively, our results show that Val493 and
Cys494 in the B30.2/SPRY domain of TRIM22 are critical for the
presence of TRIM22 within NB. We cannot exclude the possibility
that TRIM22 is targeted to pre-existing NB whose component(s)
interact with TRIM22 via Val493 and Cys494. Identifying the pro-
teins that interact with TRIM22 within NB would be important
for determining if TRIM22 drives the formation of NB, or if other
proteins drive this process. It has been reported that mutations
in B30.2/SPRY domains of other TRIM proteins such as TRIM5a
and TRIM18/MID1 modulate retroviral restriction speciﬁcity and
cause congenital abnormalities, respectively [39,40]. We suggest
that Val493 and Cys494 in TRIM22’s B30.2/SPRY domain are likely
to be functionally important.
In conclusion, this study has identiﬁed domains/residues that
are critical for the nuclear localization and NB formation of
TRIM22. Firstly, the RING domain is essential for TRIM22 NB for-
mation but mutation of Cys15 and Cys18 did not affect NB forma-
tion. It is reasonable to postulate that these two hydrophilic
residues are exposed outside for E3 ligase activity but are not re-
quired for NB formation. Secondly, the putative bipartite NLS is
necessary but not sufﬁcient for the nuclear localization of TRIM22
because the NLS-containing deletion mutant lacking the last nine
amino acids was localized mainly to the cytoplasm. Therefore,
the B30.2/SPRY domain of TRIM22, in particular residues 491–
494, are essential for nuclear localization and NB formation. Final-
ly, we also showed that Val493 and Cys494 are important for the
proper formation of TRIM22 NB. This is the ﬁrst study to demon-
strate the critical role of the B30.2/SPRY domain in nuclear locali-
zation and NB formation. These ﬁndings provide an impetus to
elucidating the structure of TRIM22 and its structure–function
relationship.
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